Skip to content

Evaluation of the effects of dark chocolate with 70% cocoa on cardiovascular health in patients with heart failure

Evaluation of the effects of dark chocolate with 70% cocoa on hemodynamic and endothelial parameteres in patients with heart failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-59xfk3
Enrollment
Unknown
Registered
2017-11-07
Start date
2016-04-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

Experimental group: 9 patients submitted to daily consumption of 50g of dark chocolate with 70% of cocoa (Theobroma cacao) offered by the researchers during the 4 week period. Chocolates were distri
Dietary supplement
B01.650.940.800.575.100.915.144
SP6.051.227

Sponsors

Programa de Pós Graduação em Ciências Cardiovasculares
Lead Sponsor
Clínica de Insuficiência Cardíaca Coração Valente
Collaborator

Eligibility

Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Sedentary men or women between the ages of 40 and 80;Body mass index (BMI) above 18.5 kg / m 2 for both sexes;Stage 1, 2 and 3 ICC according to the NYHA classification criteria, (1994)

Exclusion criteria

Exclusion criteria: In use of any dietary supplement you have in your formulation Antioxidant nutrient and chocolate;Creatinine clearance less than 60 mL / min; Smokers or former smokers (less than two years of Smoking);Liver and / or pancreatic disease;Unstable angina pectoris; Allergy to chocolate or its derivatives;Patients with stage 4 heart failure according to the criterion of NYHA classification (1994); Physical examination with presence of edema;Presence of infectious, autoimmune or immunosuppressive disease; Presence of cardiac cachexia;Presence of hypoalbuminemia;Use of pacemaker;

Design outcomes

Primary

MeasureTime frame
To evaluate the effects of the ingestion of ChA with 70% cocoa on the inflammatory profile by measuring the lipid profile of the lipid profile by measuring the total cholesterol (mg / dL), HDL- (Mg / dL), LDL-cholesterol (mg / dL) and triglycerides (TG) (mg / dL), glycogen profile by measuring glycated hemoglobin (%), fasting glucose (mg / dL), anthropometric value BMI (kg / m2), abdominal circumference (cm), conicity index and waist / height ratio and body composition (WC) by fat mass (%) and lean mass (%) by bioimpedance and dual-emission x-ray absorptiometry (DEXA) of patients with heart failure . It was expected to find a reduction of 20 mg / dL of the CT value, an increase of 10 mg / dL of HDL-cholesterol, a reduction of 10 mg / dL of LDL-cholesterol and a reduction of 20 mg / dL of TG values. In the values of glycated hemoglobin it was expected to find a reduction of 2%, of fasting glucose 15 mg / dL, as for the value of the US-PCR was expected to find a reduction of 0.2 mg / dL. As for the values of anthropometry it was expected to find a reduction of the abdominal circumference of 2 cm, the waist / height ratio of 0.1 and the taper index of 0.5. In the CC evaluation it was expected to find a fat mass reduction of 2%. ;Improvement of the lipid profile after consumption of ChA with 70% cocoa, by a significant increase of HDL-cholesterol (mg / dL): 39 ± 9.3 vs 44 ± 11 and significant reduction of triglycerides (mg / dL): 138 ± 62.4 vs 114 ± 46 (p 0.05) was found in the percentage of fat mass (%) before and After consumption of dark chocolate 37.54 ± 6.87 vs. 37.73 ± 6.96, respectively.

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactGabrielle Rocha

Faculdade de Nutrição- UFF

profgabrielle.rocha2@globo.com+55(21)26299846

Outcome results

None listed

Source: REBEC (via WHO ICTRP)